Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mushi Ye

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Genes & Genomics|February 24, 2026
Histone lactatation-related genes GPR19 and SLC22A16 are important diagnostic markers and drug treatment targets for prostate cancerYunkun Yan, Zhuo Li, Mushi Ye, et al.
Asian Journal of Surgery|March 3, 2024
Bilateral primary testicular diff use large B-cell lymphoma in a middle-aged patientYurong Ye, Jian Song, Yuanwei Chen, et al.
Disease Markers|January 10, 2022
lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell InfiltrationYunkun Yan, Jianjun Liu, Zhijian Xu, et al.
Disease Markers|June 23, 2022
Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder CancerYunkun Yan, Jianchang Li, Mushi Ye, et al.
Oncology Letters|September 15, 2018
A Mushi Ye, Zhuobin He, Wei Dai, et al.
Journal of Healthcare Engineering|March 10, 2022
Effect and Role of miR-196b in Ectopic PregnancyShan Deng, Xiaofeng Su, Xiaoling Li, et al.
Oncology Letters|September 16, 2020
Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cellsMushi Ye, Huanshu Tian, Shanhong Lin, et al.
Medicine|August 3, 2017
Varicoceles affect semen quality of infertile men in Southern China: A cross-sectional study of 5447 casesYunshan Zhang, Tianzhong Ma, Zexuan Su, et al.
Frontiers in Oncology|July 13, 2023
Synchronous multiple primary malignancies of clear cell renal cell carcinoma with sarcomatoid, thyroid carcinoma: a case reportYaxian Tan, Xiaowen Chen, Mushi Ye, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 28, 2025
JS-K enhances renal cell carcinoma radiosensitivity through the Wnt/β-catenin signaling pathway and inhibits DNA damage repairYuwan Zhao, Xinghua Lin, Wenfeng Zeng, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Genes & Genomics|February 24, 2026
Histone lactatation-related genes GPR19 and SLC22A16 are important diagnostic markers and drug treatment targets for prostate cancerYunkun Yan, Zhuo Li, Mushi Ye, et al.
Asian Journal of Surgery|March 3, 2024
Bilateral primary testicular diff use large B-cell lymphoma in a middle-aged patientYurong Ye, Jian Song, Yuanwei Chen, et al.
Disease Markers|January 10, 2022
lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell InfiltrationYunkun Yan, Jianjun Liu, Zhijian Xu, et al.
Disease Markers|June 23, 2022
Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder CancerYunkun Yan, Jianchang Li, Mushi Ye, et al.
Oncology Letters|September 15, 2018
A Mushi Ye, Zhuobin He, Wei Dai, et al.
Journal of Healthcare Engineering|March 10, 2022
Effect and Role of miR-196b in Ectopic PregnancyShan Deng, Xiaofeng Su, Xiaoling Li, et al.
Oncology Letters|September 16, 2020
Resveratrol inhibits proliferation and promotes apoptosis via the androgen receptor splicing variant 7 and PI3K/AKT signaling pathway in LNCaP prostate cancer cellsMushi Ye, Huanshu Tian, Shanhong Lin, et al.
Medicine|August 3, 2017
Varicoceles affect semen quality of infertile men in Southern China: A cross-sectional study of 5447 casesYunshan Zhang, Tianzhong Ma, Zexuan Su, et al.
Frontiers in Oncology|July 13, 2023
Synchronous multiple primary malignancies of clear cell renal cell carcinoma with sarcomatoid, thyroid carcinoma: a case reportYaxian Tan, Xiaowen Chen, Mushi Ye, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 28, 2025
JS-K enhances renal cell carcinoma radiosensitivity through the Wnt/β-catenin signaling pathway and inhibits DNA damage repairYuwan Zhao, Xinghua Lin, Wenfeng Zeng, et al.
Pageof 1